|
J. Biol. Chem., Vol. 261, Issue 12, 5314-5319, Apr, 1986
Purification of ricin A1, A2, and B chains and characterization of their toxicity
RJ Fulton, DC Blakey, PP Knowles, JW Uhr, PE Thorpe and ES Vitetta
This paper describes a protocol for the preparation of highly purified A
(A1 and A2) and B chains of the plant toxin, ricin, and biochemical and
biological characterization of these proteins. Intact ricin was bound to
acid-treated Sepharose 4B and was split on the column into A and B chains
with 2-mercaptoethanol. The A chains were eluted with borate buffer
containing 2-mercaptoethanol. A1 and A2 were then partially separated by
cation exchange chromatography and the contaminating B chain was removed by
affinity chromatography on Sepharose-asialofetuin and Sepharose-monoclonal
anti-B chain. The B chain was eluted from the Sepharose 4B column by
treatment with galactose and was further purified by cation and anion
exchange chromatography; contaminating A chains were removed by affinity
chromatography on Sepharose-monoclonal anti-A chain. The purified A and B
chains were active as determined by their ability to inhibit protein
synthesis in a cell-free assay and their binding to asialofetuin,
respectively. Furthermore, by polyacrylamide gel electrophoresis, toxicity
in mice, and toxicity on several different cell types, both A and B chains
were shown to be minimally cross-contaminated. Finally, it was shown that
ammonium chloride significantly enhanced the nonspecific toxicity of B
chains for cells in vitro. In contrast, ammonium chloride did not enhance
either the nonspecific toxicity of A chains in vitro or the specific
toxicity of A chain-containing immunotoxins prepared with the highly
purified A1, A2 chains.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. A. Messmann, E. S. Vitetta, D. Headlee, A. M. Senderowicz, W. D. Figg, J. Schindler, D. F. Michiel, S. Creekmore, S. M. Steinberg, D. Kohler, et al.
A Phase I Study of Combination Therapy with Immunotoxins IgG-HD37-Deglycosylated Ricin A Chain (dgA) and IgG-RFB4-dgA (Combotox) in Patients with Refractory CD19(+), CD22(+) B Cell Lymphoma
Clin. Cancer Res.,
April 1, 2000;
6(4):
1302 - 1313.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Chignola, C. Anselmi, M. D. Serra, A. Franceschi, G. Fracasso, M. Pasti, E. Chiesa, J. M. Lord, G. Tridente, and M. Colombatti
Self-potentiation of Ligand-Toxin Conjugates Containing Ricin A Chain Fused with Viral Structures
J. Biol. Chem.,
October 6, 1995;
270(40):
23345 - 23351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Vitetta, R. Fulton, R. May, M Till, and J. Uhr
Redesigning nature's poisons to create anti-tumor reagents
Science,
November 20, 1987;
238(4830):
1098 - 1104.
[Abstract]
[PDF]
|
 |
|
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|